Charles Gayer

Chief Executive Officer at BIOCRYST PHARMACEUTICALS, INC.

Net worth: 4 M $ as of 30/06/2026

55 year

Health Technology

Consumer Services

Profile

Charles K.
Gayer is President, Chief Executive Officer & Director at BioCryst Pharmaceuticals, Inc. since 2026.
Formerly, Mr. Gayer was Head-US & Global Commercial Business at Grifols Therapeutics, Inc. Education includes an undergraduate degree from Princeton University and an MBA from The Fuqua School of Business.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
BIOCRYST PHARMACEUTICALS, INC. 0.14%	13/04/2026	364,620 ( 0.14% )	4 M $	30/06/2026

Charles Gayer active positions

Companies	Position	Start
BIOCRYST PHARMACEUTICALS, INC.	Chief Executive Officer	01/01/2026

All active positions of Charles Gayer

Former positions of Charles Gayer

Companies	Position	End
Grifols Therapeutics, Inc. Grifols Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops therapeutic products	Corporate Officer/Principal	-

See the detail of Charles Gayer's experience

Training of Charles Gayer

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Charles Gayer's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
BioCryst Pharmaceuticals, Inc. BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics	Health Technology
Princeton University Princeton University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Grifols Therapeutics, Inc. Grifols Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops therapeutic products	Health Technology
The Fuqua School of Business The Fuqua School of Business Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services